-
2
-
-
20544453277
-
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology
-
Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005, 26:1115-1140.
-
(2005)
Eur Heart J
, vol.26
, pp. 1115-1140
-
-
Swedberg, K.1
Cleland, J.2
Dargie, H.3
-
3
-
-
20044379730
-
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology
-
Nieminen M.S., Böhm M., Cowie M.R., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005, 26:384-416.
-
(2005)
Eur Heart J
, vol.26
, pp. 384-416
-
-
Nieminen, M.S.1
Böhm, M.2
Cowie, M.R.3
-
4
-
-
24944563849
-
American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)
-
ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)
-
Hunt S.A., American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005, 46:e1-e82.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. e1-e82
-
-
Hunt, S.A.1
-
5
-
-
33144483487
-
Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline
-
Adams K.F., Lindenfeld J., Arnold J.M.O., Baker D.W., Barnard D.H., Baughman K.L. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 2006, 12:10-38.
-
(2006)
J Card Fail
, vol.12
, pp. 10-38
-
-
Adams, K.F.1
Lindenfeld, J.2
Arnold, J.M.O.3
Baker, D.W.4
Barnard, D.H.5
Baughman, K.L.6
-
6
-
-
0034649248
-
Congestive heart failure: fifty years of progress
-
Braunwald E., Bristow M.R. Congestive heart failure: fifty years of progress. Circulation 2000, 102(20 Suppl. 4):IV14-IV23.
-
(2000)
Circulation
, vol.102
, Issue.20
, pp. IV14-IV23
-
-
Braunwald, E.1
Bristow, M.R.2
-
7
-
-
0032537621
-
Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure
-
Dipla K., Mattiello J.A., Jeevanandam V., Houser S.R., Margulies K.B. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 1998, 97:2316-2322.
-
(1998)
Circulation
, vol.97
, pp. 2316-2322
-
-
Dipla, K.1
Mattiello, J.A.2
Jeevanandam, V.3
Houser, S.R.4
Margulies, K.B.5
-
8
-
-
0029845123
-
Medical therapy can improve the biologic properties of the chronically failing heart: a new era in the treatment of heart failure
-
Eichhorn E.J., Bristow M.R. Medical therapy can improve the biologic properties of the chronically failing heart: a new era in the treatment of heart failure. Circulation 1996, 94:2285-2296.
-
(1996)
Circulation
, vol.94
, pp. 2285-2296
-
-
Eichhorn, E.J.1
Bristow, M.R.2
-
9
-
-
44949196630
-
Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice
-
Vittorini S., Clerico A. Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice. Clin Chem Lab Med 2008, 46:748-763.
-
(2008)
Clin Chem Lab Med
, vol.46
, pp. 748-763
-
-
Vittorini, S.1
Clerico, A.2
-
10
-
-
3042706302
-
Role and importance of biochemical markers in clinical cardiology
-
Panteghini M. Role and importance of biochemical markers in clinical cardiology. Eur Heart J 2004, 25:1187-1196.
-
(2004)
Eur Heart J
, vol.25
, pp. 1187-1196
-
-
Panteghini, M.1
-
12
-
-
33751513756
-
Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart faille: a clinical review
-
De Virginy D.R. Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart faille: a clinical review. Heart Fail Rev 2006, 11:333-334.
-
(2006)
Heart Fail Rev
, vol.11
, pp. 333-334
-
-
De Virginy, D.R.1
-
13
-
-
33745004785
-
Biomarkers of cardiovascular disease: molecular basis and practical considerations
-
Vasan S. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006, 113:2335-2362.
-
(2006)
Circulation
, vol.113
, pp. 2335-2362
-
-
Vasan, S.1
-
14
-
-
34848881071
-
Biomarkers for chronic heart failure
-
Lainscak M., von Haehling S., Springer J., Anker S.D. Biomarkers for chronic heart failure. Heart Fail Monit 2007, 5:77-82.
-
(2007)
Heart Fail Monit
, vol.5
, pp. 77-82
-
-
Lainscak, M.1
von Haehling, S.2
Springer, J.3
Anker, S.D.4
-
15
-
-
43549099569
-
Biomarkers in heart failure
-
Braunwald E. Biomarkers in heart failure. N Engl J Med 2008, 358:2148-2159.
-
(2008)
N Engl J Med
, vol.358
, pp. 2148-2159
-
-
Braunwald, E.1
-
16
-
-
66249144415
-
Old and new biomarkers of heart failure
-
Emdin M., Vittorini S., Passino C., Clerico A. Old and new biomarkers of heart failure. Eur J Heart Fail 2009, 11:331-335.
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 331-335
-
-
Emdin, M.1
Vittorini, S.2
Passino, C.3
Clerico, A.4
-
17
-
-
0141995037
-
Cardiac natriuretic peptides: a proteomic window to cardiac function and clinical management
-
Maisel A.S., McCullough P.A. Cardiac natriuretic peptides: a proteomic window to cardiac function and clinical management. Rev Cardiovasc Med 2003, 4(Suppl. 4):S3-S12.
-
(2003)
Rev Cardiovasc Med
, vol.4
, pp. S3-S12
-
-
Maisel, A.S.1
McCullough, P.A.2
-
18
-
-
84865264018
-
Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care
-
Thygesen K., Mair J., Mueller C., et al. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J 2012, 33:2001-2006.
-
(2012)
Eur Heart J
, vol.33
, pp. 2001-2006
-
-
Thygesen, K.1
Mair, J.2
Mueller, C.3
-
19
-
-
84884294190
-
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
-
Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013, 62:e147-e239.
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. e147-e239
-
-
Yancy, C.W.1
Jessup, M.2
Bozkurt, B.3
-
20
-
-
33644795655
-
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications
-
Clerico A., Recchia F.A., Passino C., Emdin M. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol 2006, 290:H17-H29.
-
(2006)
Am J Physiol Heart Circ Physiol
, vol.290
, pp. H17-H29
-
-
Clerico, A.1
Recchia, F.A.2
Passino, C.3
Emdin, M.4
-
21
-
-
79959895425
-
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones
-
Clerico A., Giannoni A., Vittorini S., Passino C. Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones. Am J Physiol Heart Circ Physiol 2011, 301:H12-H20.
-
(2011)
Am J Physiol Heart Circ Physiol
, vol.301
, pp. H12-H20
-
-
Clerico, A.1
Giannoni, A.2
Vittorini, S.3
Passino, C.4
-
22
-
-
69549111749
-
Clinical relevance of BNP measurement in the follow-up of patients with chronic heart failure
-
Clerico A., Fontana M., Ripoli A., Emdin M. Clinical relevance of BNP measurement in the follow-up of patients with chronic heart failure. Adv Clin Chem 2009, 48:163-179.
-
(2009)
Adv Clin Chem
, vol.48
, pp. 163-179
-
-
Clerico, A.1
Fontana, M.2
Ripoli, A.3
Emdin, M.4
-
24
-
-
68849114272
-
Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials
-
Felker G.M., Hasselblad V., Hernandez A.F., O'Connor C.M. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Am Heart J 2009, 158:422-430.
-
(2009)
Am Heart J
, vol.158
, pp. 422-430
-
-
Felker, G.M.1
Hasselblad, V.2
Hernandez, A.F.3
O'Connor, C.M.4
-
25
-
-
77951059915
-
B-type natriuretic peptide-guided heart failure therapy: a meta-analysis
-
Porapakkham P., Porapakkham P., Zimmet H., Billah B., Krum H. B-type natriuretic peptide-guided heart failure therapy: a meta-analysis. Arch Intern Med 2010, 170:507-514.
-
(2010)
Arch Intern Med
, vol.170
, pp. 507-514
-
-
Porapakkham, P.1
Porapakkham, P.2
Zimmet, H.3
Billah, B.4
Krum, H.5
-
26
-
-
84902577748
-
Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis
-
Troughton R.W., Frampton C.M., Brunner-La Rocca H.P., et al. Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis. Eur Heart J 2014, 35:1559-1567.
-
(2014)
Eur Heart J
, vol.35
, pp. 1559-1567
-
-
Troughton, R.W.1
Frampton, C.M.2
Brunner-La Rocca, H.P.3
-
27
-
-
84873110684
-
Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management
-
Januzzi J.L., Troughton R. Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management. Circulation 2013, 127:500-507.
-
(2013)
Circulation
, vol.127
, pp. 500-507
-
-
Januzzi, J.L.1
Troughton, R.2
-
28
-
-
73349131123
-
High-sensitivity troponin: a new toll for pathophysiological investigation and clinical practice
-
Clerico A., Giannoni A., Prontera T., Giovannini S. High-sensitivity troponin: a new toll for pathophysiological investigation and clinical practice. Adv Clin Chem 2009, 49:1-30.
-
(2009)
Adv Clin Chem
, vol.49
, pp. 1-30
-
-
Clerico, A.1
Giannoni, A.2
Prontera, T.3
Giovannini, S.4
-
29
-
-
84856068587
-
Analytical characteristics of high-sensitivity cardiac troponin assay
-
Apple F.S., Collinson P.O. Analytical characteristics of high-sensitivity cardiac troponin assay. Clin Chem 2012, 58:54-61.
-
(2012)
Clin Chem
, vol.58
, pp. 54-61
-
-
Apple, F.S.1
Collinson, P.O.2
-
30
-
-
0041431119
-
Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure
-
Horwich T.B., Patel J., MacLellan W.R., et al. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003, 108:833-838.
-
(2003)
Circulation
, vol.108
, pp. 833-838
-
-
Horwich, T.B.1
Patel, J.2
MacLellan, W.R.3
-
31
-
-
0035936510
-
Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes
-
Sato Y., Yamada T., Taniguchi R., et al. Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001, 103:369-374.
-
(2001)
Circulation
, vol.103
, pp. 369-374
-
-
Sato, Y.1
Yamada, T.2
Taniguchi, R.3
-
32
-
-
0032842145
-
Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure
-
[A9]
-
Setsuta K., Seino Y., Takahashi N., et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 1999, 84:608-611. [A9].
-
(1999)
Am J Cardiol
, vol.84
, pp. 608-611
-
-
Setsuta, K.1
Seino, Y.2
Takahashi, N.3
-
33
-
-
2342440919
-
Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis
-
Hudson M.P., O'Connor C.M., Gattis W.A., et al. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. Am Heart J 2004, 147:546-552.
-
(2004)
Am Heart J
, vol.147
, pp. 546-552
-
-
Hudson, M.P.1
O'Connor, C.M.2
Gattis, W.A.3
-
34
-
-
37549061014
-
Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE
-
Fonarow G.C., Peacock W.F., Horwich T.B., et al. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Am J Cardiol 2008, 101:231-237.
-
(2008)
Am J Cardiol
, vol.101
, pp. 231-237
-
-
Fonarow, G.C.1
Peacock, W.F.2
Horwich, T.B.3
-
35
-
-
43549083514
-
Cardiac troponin and outcome in acute heart failure
-
Peacock W.F.I.V., De Marco T., Fonarow G.C., et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008, 358:2117-2126.
-
(2008)
N Engl J Med
, vol.358
, pp. 2117-2126
-
-
Peacock, W.F.I.V.1
De Marco, T.2
Fonarow, G.C.3
-
36
-
-
46849116888
-
Clinical significance of cardiac troponins I and T in acute heart failure
-
Ilva T., Lassus J., Siirila-Waris K., et al. Clinical significance of cardiac troponins I and T in acute heart failure. Eur J Heart Fail 2008, 10:772-779.
-
(2008)
Eur J Heart Fail
, vol.10
, pp. 772-779
-
-
Ilva, T.1
Lassus, J.2
Siirila-Waris, K.3
-
37
-
-
0030723975
-
Circulating cardiac troponin I in severe congestive heart failure
-
Missov E., Calzolari C., Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997, 96:2953-2958.
-
(1997)
Circulation
, vol.96
, pp. 2953-2958
-
-
Missov, E.1
Calzolari, C.2
Pau, B.3
-
38
-
-
84873412696
-
Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure
-
Ather S., Hira R.S., Shenoy M., et al. Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure. Int J Cardiol 2011, 301:H2351-H2361.
-
(2011)
Int J Cardiol
, vol.301
, pp. H2351-H2361
-
-
Ather, S.1
Hira, R.S.2
Shenoy, M.3
-
39
-
-
84866400461
-
Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: heart failure section
-
Januzzi J.L., Filippatos G., Nieminen M., et al. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: heart failure section. Eur Heart J 2012, 33:2265-2271.
-
(2012)
Eur Heart J
, vol.33
, pp. 2265-2271
-
-
Januzzi, J.L.1
Filippatos, G.2
Nieminen, M.3
-
40
-
-
79960350455
-
Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival
-
Tang W.H., Shrestha K., Shao Z., et al. Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival. Am J Cardiol 2011, 108:385-390.
-
(2011)
Am J Cardiol
, vol.108
, pp. 385-390
-
-
Tang, W.H.1
Shrestha, K.2
Shao, Z.3
-
41
-
-
78651387589
-
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
-
de Boer R.A., Lok D.J., Jaarsma T., et al. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med 2011, 43:60-68.
-
(2011)
Ann Med
, vol.43
, pp. 60-68
-
-
de Boer, R.A.1
Lok, D.J.2
Jaarsma, T.3
-
42
-
-
77954658143
-
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
-
Lok D.J., van der Meer P., de la Porte P.W., et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol 2010, 99:323-328.
-
(2010)
Clin Res Cardiol
, vol.99
, pp. 323-328
-
-
Lok, D.J.1
van der Meer, P.2
de la Porte, P.W.3
-
43
-
-
77955463871
-
Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure
-
Shah R.V., Chen-Tournoux A.A., Picard M.H., et al. Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure. Eur J Heart Fail 2010, 12:826-832.
-
(2010)
Eur J Heart Fail
, vol.12
, pp. 826-832
-
-
Shah, R.V.1
Chen-Tournoux, A.A.2
Picard, M.H.3
-
44
-
-
84859639923
-
Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study
-
Felker G.M., Fiuzat M., Shaw L.K., et al. Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study. Circ Heart Fail 2012, 5:72-78.
-
(2012)
Circ Heart Fail
, vol.5
, pp. 72-78
-
-
Felker, G.M.1
Fiuzat, M.2
Shaw, L.K.3
-
45
-
-
84870482586
-
Galectin 3 complements BNP in risk stratification in acute heart failure
-
Fermann G.J., Lindsell C.J., Storrow A.B., et al. Galectin 3 complements BNP in risk stratification in acute heart failure. Biomarkers 2012, 17:706-713.
-
(2012)
Biomarkers
, vol.17
, pp. 706-713
-
-
Fermann, G.J.1
Lindsell, C.J.2
Storrow, A.B.3
-
46
-
-
84555204713
-
Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial
-
Lopez-Andrès N., Rossignol P., Iraqi W., et al. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial. Eur J Heart Fail 2012, 14:74-81.
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 74-81
-
-
Lopez-Andrès, N.1
Rossignol, P.2
Iraqi, W.3
-
47
-
-
84877106997
-
Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT
-
Anand I.S., Rector T.S., Kuskowski M., et al. Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT. Eur J Heart Fail 2013, 15:511-518.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 511-518
-
-
Anand, I.S.1
Rector, T.S.2
Kuskowski, M.3
-
48
-
-
84887625229
-
Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction
-
Carrasco-Sánchez F.J., Aramburu-Bodas O., Salamanca-Bautista P., et al. Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction. Int J Cardiol 2013, 169:177-182.
-
(2013)
Int J Cardiol
, vol.169
, pp. 177-182
-
-
Carrasco-Sánchez, F.J.1
Aramburu-Bodas, O.2
Salamanca-Bautista, P.3
-
49
-
-
84878544017
-
Predictive value of plasma galectin-3 in patients with chronic heart failure
-
Chen K., Jiang R.J., Wang C.Q., et al. Predictive value of plasma galectin-3 in patients with chronic heart failure. Eur Rev Med Pharmacol Sci 2013, 17:1005-1011.
-
(2013)
Eur Rev Med Pharmacol Sci
, vol.17
, pp. 1005-1011
-
-
Chen, K.1
Jiang, R.J.2
Wang, C.Q.3
-
50
-
-
84885058278
-
Galectin-3 in heart failure with preserved ejection fraction
-
de Boer R.A., Edelmann F., Cohen-Solal A., Mamas M.A., Maisel A., Pieske B. Galectin-3 in heart failure with preserved ejection fraction. Eur J Heart Fail 2013, 15:1095-1101.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 1095-1101
-
-
de Boer, R.A.1
Edelmann, F.2
Cohen-Solal, A.3
Mamas, M.A.4
Maisel, A.5
Pieske, B.6
-
51
-
-
84886698796
-
Incremental prognostic power of novel biomarkers (growth-differentiation factor-15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failure
-
Lok D.J., Klip I.T., Lok S.I., et al. Incremental prognostic power of novel biomarkers (growth-differentiation factor-15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failure. Am J Cardiol 2013, 112:831-837.
-
(2013)
Am J Cardiol
, vol.112
, pp. 831-837
-
-
Lok, D.J.1
Klip, I.T.2
Lok, S.I.3
-
52
-
-
84885044150
-
Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study
-
Motiwala S.R., Szymonifka J., Belcher A., et al. Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study. Eur J Heart Fail 2013, 15:1157-1163.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 1157-1163
-
-
Motiwala, S.R.1
Szymonifka, J.2
Belcher, A.3
-
53
-
-
84877246724
-
Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH
-
van der Velde A.R., Gullestad L., Ueland T., et al. Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH. Circ Heart Fail 2013, 6:219-226.
-
(2013)
Circ Heart Fail
, vol.6
, pp. 219-226
-
-
van der Velde, A.R.1
Gullestad, L.2
Ueland, T.3
-
54
-
-
34547582106
-
Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study
-
Januzzi J.L., Peacock W.F., Maisel A.S., et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol 2007, 50:607-613.
-
(2007)
J Am Coll Cardiol
, vol.50
, pp. 607-613
-
-
Januzzi, J.L.1
Peacock, W.F.2
Maisel, A.S.3
-
55
-
-
42449133778
-
Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure
-
Mueller T., Dieplinger B., Gegenhuber A., Poelz W., Pacher R., Haltmayer M. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure. Clin Chem 2008, 54:752-756.
-
(2008)
Clin Chem
, vol.54
, pp. 752-756
-
-
Mueller, T.1
Dieplinger, B.2
Gegenhuber, A.3
Poelz, W.4
Pacher, R.5
Haltmayer, M.6
-
56
-
-
53949108120
-
Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure
-
Rehman S.U., Mueller T., Januzzi J.L. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol 2008, 52:1458-1465.
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 1458-1465
-
-
Rehman, S.U.1
Mueller, T.2
Januzzi, J.L.3
-
57
-
-
78650868251
-
Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction
-
Manzano-Fernandez S., Mueller T., Pascual-Figal D., et al. Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction. Am J Cardiol 2011, 107:259-267.
-
(2011)
Am J Cardiol
, vol.107
, pp. 259-267
-
-
Manzano-Fernandez, S.1
Mueller, T.2
Pascual-Figal, D.3
-
58
-
-
84859219085
-
ST2 has diagnostic and prognostic utility for all-cause mortality and heart failure in patients presenting to the emergency department with chest pain
-
Aldous S.J., Richards A.M., Troughton R., Than M. ST2 has diagnostic and prognostic utility for all-cause mortality and heart failure in patients presenting to the emergency department with chest pain. J Card Fail 2012, 18:304-310.
-
(2012)
J Card Fail
, vol.18
, pp. 304-310
-
-
Aldous, S.J.1
Richards, A.M.2
Troughton, R.3
Than, M.4
-
59
-
-
84860675846
-
Soluble ST2 as a diagnostic and prognostic marker for acute heart failure syndromes
-
Henry-Okafor Q., Collins S.P., Jenkins C.A., et al. Soluble ST2 as a diagnostic and prognostic marker for acute heart failure syndromes. Open Biomark J 2012, 2012:1-8.
-
(2012)
Open Biomark J
, vol.2012
, pp. 1-8
-
-
Henry-Okafor, Q.1
Collins, S.P.2
Jenkins, C.A.3
-
60
-
-
84888056391
-
Soluble ST2 serum concentration and renal function in heart failure
-
Bayes-Genis A., Zamora E., de Antonio M., et al. Soluble ST2 serum concentration and renal function in heart failure. J Card Fail 2013, 19:768-775.
-
(2013)
J Card Fail
, vol.19
, pp. 768-775
-
-
Bayes-Genis, A.1
Zamora, E.2
de Antonio, M.3
-
61
-
-
84890253068
-
Heart failure therapy-induced early ST2 changes may offer long-term therapy guidance
-
Breidthardt T., Balmelli C., Twerenbold R., et al. Heart failure therapy-induced early ST2 changes may offer long-term therapy guidance. J Card Fail 2013, 19:821-828.
-
(2013)
J Card Fail
, vol.19
, pp. 821-828
-
-
Breidthardt, T.1
Balmelli, C.2
Twerenbold, R.3
-
62
-
-
84874610413
-
Soluble ST2 is associated with all-cause and cardiovascular mortality in a population-based cohort: the Dallas Heart Study
-
Chen L.Q., de Lemos J.A., Das S.R., Ayers C.R., Rohatgi A. Soluble ST2 is associated with all-cause and cardiovascular mortality in a population-based cohort: the Dallas Heart Study. Clin Chem 2013, 59:536-546.
-
(2013)
Clin Chem
, vol.59
, pp. 536-546
-
-
Chen, L.Q.1
de Lemos, J.A.2
Das, S.R.3
Ayers, C.R.4
Rohatgi, A.5
-
63
-
-
84875173419
-
Soluble ST2 as a biomarker for detecting stable heart failure with a normal ejection fraction in hypertensive patients
-
Wang Y.C., Yu C.C., Chiu F.C., et al. Soluble ST2 as a biomarker for detecting stable heart failure with a normal ejection fraction in hypertensive patients. J Card Fail 2013, 19:163-168.
-
(2013)
J Card Fail
, vol.19
, pp. 163-168
-
-
Wang, Y.C.1
Yu, C.C.2
Chiu, F.C.3
-
64
-
-
84894070849
-
Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction
-
Gruson D., Lepoutre T., Ahn S.A., Rousseau M.F. Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction. Int J Cardiol 2014, 172:e250-e252.
-
(2014)
Int J Cardiol
, vol.172
, pp. e250-e252
-
-
Gruson, D.1
Lepoutre, T.2
Ahn, S.A.3
Rousseau, M.F.4
-
65
-
-
1042301961
-
Evaluating a new marker's predictive contribution
-
Kattan M.W. Evaluating a new marker's predictive contribution. Clin Cancer Res 2004, 10:822-824.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 822-824
-
-
Kattan, M.W.1
-
66
-
-
0037154285
-
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study
-
Assmann G., Cullen P., Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002, 105:310-315.
-
(2002)
Circulation
, vol.105
, pp. 310-315
-
-
Assmann, G.1
Cullen, P.2
Schulte, H.3
-
67
-
-
0038579421
-
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
-
Conroy R.M., Pyorala K., Fitzgerald A.P., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24:987-1003.
-
(2003)
Eur Heart J
, vol.24
, pp. 987-1003
-
-
Conroy, R.M.1
Pyorala, K.2
Fitzgerald, A.P.3
-
68
-
-
2342516164
-
Observations, predictions and decisions - assessing cardiovascular risk assessment
-
Hense H.W. Observations, predictions and decisions - assessing cardiovascular risk assessment. Int J Epidemiol 2004, 33:235-239.
-
(2004)
Int J Epidemiol
, vol.33
, pp. 235-239
-
-
Hense, H.W.1
-
69
-
-
66349111734
-
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association
-
Hlatky M.A., Greenland P., Arnett D.K., et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009, 119:2408-2416.
-
(2009)
Circulation
, vol.119
, pp. 2408-2416
-
-
Hlatky, M.A.1
Greenland, P.2
Arnett, D.K.3
-
70
-
-
78751475386
-
-
AACC Press, Washington DC
-
Price P.C., Christensen R.H. Evidence-based laboratory medicine: principles, practice, and outcome 2007, 1-545. AACC Press, Washington DC. 2nd ed.
-
(2007)
Evidence-based laboratory medicine: principles, practice, and outcome
, pp. 1-545
-
-
Price, P.C.1
Christensen, R.H.2
-
71
-
-
4344586130
-
Economic evaluation of diagnostic tests
-
AACC Press, Washington DC, P.C. Price, R.H. Christensen (Eds.)
-
Marshall D.A., O'Brien B.J. Economic evaluation of diagnostic tests. Evidence-based laboratory medicine - from principles to outcomes 2003, 159-186. AACC Press, Washington DC. P.C. Price, R.H. Christensen (Eds.).
-
(2003)
Evidence-based laboratory medicine - from principles to outcomes
, pp. 159-186
-
-
Marshall, D.A.1
O'Brien, B.J.2
-
72
-
-
79951587253
-
Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction
-
Wang T.J. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation 2011, 123:551-565.
-
(2011)
Circulation
, vol.123
, pp. 551-565
-
-
Wang, T.J.1
-
74
-
-
0042474263
-
The increasing impact of laboratory medicine on clinical cardiology
-
Clerico A. The increasing impact of laboratory medicine on clinical cardiology. Clin Chem Lab Med 2003, 41:871-883.
-
(2003)
Clin Chem Lab Med
, vol.41
, pp. 871-883
-
-
Clerico, A.1
-
75
-
-
33645791709
-
Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay
-
Clerico A., Zucchelli G.C., Pilo A., Passino C., Emdin M. Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay. Clin Chem Lab Med 2006, 44:366-378.
-
(2006)
Clin Chem Lab Med
, vol.44
, pp. 366-378
-
-
Clerico, A.1
Zucchelli, G.C.2
Pilo, A.3
Passino, C.4
Emdin, M.5
-
76
-
-
44949146084
-
Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations
-
Clerico A., Fortunato A., Ripoli A., Prontera C., Zucchelli G.C., Emdin M. Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations. Clin Chem Lab Med 2008, 46:804-808.
-
(2008)
Clin Chem Lab Med
, vol.46
, pp. 804-808
-
-
Clerico, A.1
Fortunato, A.2
Ripoli, A.3
Prontera, C.4
Zucchelli, G.C.5
Emdin, M.6
-
77
-
-
77952498617
-
Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immunoassay platform
-
Cantinotti M., Storti S., Parri M.S., Prontera C., Murzi B., Clerico A. Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immunoassay platform. Clin Chem Lab Med 2010, 48:697-700.
-
(2010)
Clin Chem Lab Med
, vol.48
, pp. 697-700
-
-
Cantinotti, M.1
Storti, S.2
Parri, M.S.3
Prontera, C.4
Murzi, B.5
Clerico, A.6
-
78
-
-
70349802010
-
Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal?
-
Giannoni A., Giovannini S., Clerico A. Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal?. Clin Chem Lab Med 2009, 47:1167-1177.
-
(2009)
Clin Chem Lab Med
, vol.47
, pp. 1167-1177
-
-
Giannoni, A.1
Giovannini, S.2
Clerico, A.3
-
79
-
-
40449126121
-
Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage
-
Luckenbill K.N., Christenson R.H., Jaffe A.S., et al. Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. Clin Chem 2008, 54:619-621.
-
(2008)
Clin Chem
, vol.54
, pp. 619-621
-
-
Luckenbill, K.N.1
Christenson, R.H.2
Jaffe, A.S.3
-
80
-
-
84856554908
-
Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance
-
Clerico A., Vittorini S., Passino C. Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance. Clin Chem Lab Med 2011, 4:1949-1954.
-
(2011)
Clin Chem Lab Med
, vol.4
, pp. 1949-1954
-
-
Clerico, A.1
Vittorini, S.2
Passino, C.3
-
81
-
-
77950280653
-
Biosynthesis of cardiac natriuretic peptides
-
Goetze J.P. Biosynthesis of cardiac natriuretic peptides. Results Probl Cell Differ 2010, 50:97-120.
-
(2010)
Results Probl Cell Differ
, vol.50
, pp. 97-120
-
-
Goetze, J.P.1
-
82
-
-
7844241913
-
Degradation of cardiac troponin I: implication for reliable immunodetection
-
Katrukha A.G., Bereznikova A.V., Filatov V.L., et al. Degradation of cardiac troponin I: implication for reliable immunodetection. Clin Chem 1998, 44:2433-2440.
-
(1998)
Clin Chem
, vol.44
, pp. 2433-2440
-
-
Katrukha, A.G.1
Bereznikova, A.V.2
Filatov, V.L.3
-
83
-
-
60749093017
-
Assay-related issues in the measurement of cardiac troponins
-
Panteghini M. Assay-related issues in the measurement of cardiac troponins. Clin Chim Acta 2009, 402:88-93.
-
(2009)
Clin Chim Acta
, vol.402
, pp. 88-93
-
-
Panteghini, M.1
-
84
-
-
77954774602
-
Standardisation of cardiac troponin I measurement: past and present
-
Tate J.R., Bunk D.M., Christenson R.H., et al. Standardisation of cardiac troponin I measurement: past and present. Pathology 2010, 42:402-408.
-
(2010)
Pathology
, vol.42
, pp. 402-408
-
-
Tate, J.R.1
Bunk, D.M.2
Christenson, R.H.3
-
85
-
-
0742304262
-
Evaluation of imprecision for cardiac troponin assays at low-range concentrations
-
Panteghini M., Pagani F., Yeo K.T., et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004, 50:327-332.
-
(2004)
Clin Chem
, vol.50
, pp. 327-332
-
-
Panteghini, M.1
Pagani, F.2
Yeo, K.T.3
-
86
-
-
0033775410
-
Measurement of natriuretic cardiac hormones (ANP, BNP, and related peptides) in clinical practice: the need for a new generation of immunoassay methods
-
Clerico A., Del Ry S., Giannessi D. Measurement of natriuretic cardiac hormones (ANP, BNP, and related peptides) in clinical practice: the need for a new generation of immunoassay methods. Clin Chem 2000, 46:1529-1534.
-
(2000)
Clin Chem
, vol.46
, pp. 1529-1534
-
-
Clerico, A.1
Del Ry, S.2
Giannessi, D.3
-
87
-
-
14644431817
-
Performance characteristics of four automated natriuretic peptide assays
-
Rawlins M.L., Owen W.E., Roberts W.L. Performance characteristics of four automated natriuretic peptide assays. Am J Clin Pathol 2005, 123:439-445.
-
(2005)
Am J Clin Pathol
, vol.123
, pp. 439-445
-
-
Rawlins, M.L.1
Owen, W.E.2
Roberts, W.L.3
-
88
-
-
14544292879
-
Quality specifications for B-type natriuretic peptide assays
-
Apple F.S., Panteghini M., Ravkilde J., et al. Quality specifications for B-type natriuretic peptide assays. Clin Chem 2005, 51:486-493.
-
(2005)
Clin Chem
, vol.51
, pp. 486-493
-
-
Apple, F.S.1
Panteghini, M.2
Ravkilde, J.3
-
89
-
-
34548404811
-
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biomarkers of heart failure
-
Apple F.S., Wu A.H., Jaffe A.S., et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biomarkers of heart failure. Circulation 2007, 116:e95-e98.
-
(2007)
Circulation
, vol.116
, pp. e95-e98
-
-
Apple, F.S.1
Wu, A.H.2
Jaffe, A.S.3
-
90
-
-
67650637716
-
Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmoCheck study
-
Prontera C., Zaninotto M., Giovannini S., et al. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmoCheck study. Clin Chem Lab Med 2009, 47:762-768.
-
(2009)
Clin Chem Lab Med
, vol.47
, pp. 762-768
-
-
Prontera, C.1
Zaninotto, M.2
Giovannini, S.3
-
91
-
-
84866481231
-
State of the art of BNP and NT-proBNP immunoassays: the CardioOrmoCheck study
-
Clerico A., Zaninotto M., Prontera C., et al. State of the art of BNP and NT-proBNP immunoassays: the CardioOrmoCheck study. Clin Chim Acta 2012, 414:112-119.
-
(2012)
Clin Chim Acta
, vol.414
, pp. 112-119
-
-
Clerico, A.1
Zaninotto, M.2
Prontera, C.3
-
92
-
-
0031800740
-
Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I
-
Wu A.H.B., Feng Y.J., Moore R., et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 1998, 44:1198-1208.
-
(1998)
Clin Chem
, vol.44
, pp. 1198-1208
-
-
Wu, A.H.B.1
Feng, Y.J.2
Moore, R.3
-
93
-
-
84856074170
-
Standardization of cardiac troponin I assays will not occur in my lifetime
-
Apple F.S. Standardization of cardiac troponin I assays will not occur in my lifetime. Clin Chem 2012, 58:169-171.
-
(2012)
Clin Chem
, vol.58
, pp. 169-171
-
-
Apple, F.S.1
-
94
-
-
0035102976
-
Standardization of cardiac troponin I assays: round robin of ten candidate reference materials
-
Christenson R.H., Duh S.H., Apple F.S., et al. Standardization of cardiac troponin I assays: round robin of ten candidate reference materials. Clin Chem 2001, 47:431-437.
-
(2001)
Clin Chem
, vol.47
, pp. 431-437
-
-
Christenson, R.H.1
Duh, S.H.2
Apple, F.S.3
-
95
-
-
84856075410
-
IFCC Working Group on Standardization of Troponin I Point: put simply, standardization of cardiac troponin I is complicated
-
Christenson R.H., Bunk D.M., Schimmel H., Tate J.R., IFCC Working Group on Standardization of Troponin I Point: put simply, standardization of cardiac troponin I is complicated. Clin Chem 2012, 58:165-168.
-
(2012)
Clin Chem
, vol.58
, pp. 165-168
-
-
Christenson, R.H.1
Bunk, D.M.2
Schimmel, H.3
Tate, J.R.4
-
96
-
-
84872388578
-
Harmonization of measurement procedures: how do we get it done?
-
Gantzer M.L., Miller W.G. Harmonization of measurement procedures: how do we get it done?. Clin Biochem Rev 2012, 33:95-100.
-
(2012)
Clin Biochem Rev
, vol.33
, pp. 95-100
-
-
Gantzer, M.L.1
Miller, W.G.2
-
97
-
-
79953127847
-
Harmonization of free thyroid hormone test: a mission impossible?
-
Iervasi G., Clerico A. Harmonization of free thyroid hormone test: a mission impossible?. Clin Chem Lab Med 2011, 49:43-48.
-
(2011)
Clin Chem Lab Med
, vol.49
, pp. 43-48
-
-
Iervasi, G.1
Clerico, A.2
-
98
-
-
33847358624
-
Evidence for functional heterogeneity of circulating B-type natriuretic peptide
-
Liang F., O'Rear J., Schellenberger U., et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coll Cardiol 2007, 49:1071-1078.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 1071-1078
-
-
Liang, F.1
O'Rear, J.2
Schellenberger, U.3
-
99
-
-
4344588833
-
Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited
-
Goetze J.P. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin Chem 2004, 49:1503-1510.
-
(2004)
Clin Chem
, vol.49
, pp. 1503-1510
-
-
Goetze, J.P.1
-
100
-
-
4043094879
-
ProBNP-derived peptides in cardiac disease
-
Goetze J.P. ProBNP-derived peptides in cardiac disease. Scand J Clin Lab Invest 2004, 64:497-510.
-
(2004)
Scand J Clin Lab Invest
, vol.64
, pp. 497-510
-
-
Goetze, J.P.1
-
101
-
-
33646916875
-
Assay for measurement of intact B-type natriuretic peptide prohormone in blood
-
Giuliani I., Rieunier F., Larue C., et al. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 2006, 52:1054-1061.
-
(2006)
Clin Chem
, vol.52
, pp. 1054-1061
-
-
Giuliani, I.1
Rieunier, F.2
Larue, C.3
-
102
-
-
34248336125
-
The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure
-
Seferian K.R., Tamm N.N., Semenov A.G., et al. The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure. Clin Chem 2007, 53:866-873.
-
(2007)
Clin Chem
, vol.53
, pp. 866-873
-
-
Seferian, K.R.1
Tamm, N.N.2
Semenov, A.G.3
-
103
-
-
43449109489
-
Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure
-
Hammerer-Lercher A., Halfinger B., Sarg B., et al. Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure. Clin Chem 2008, 54:858-865.
-
(2008)
Clin Chem
, vol.54
, pp. 858-865
-
-
Hammerer-Lercher, A.1
Halfinger, B.2
Sarg, B.3
-
104
-
-
70549085028
-
Peptide hormones and their prohormones as biomarkers
-
Goetze J.P., Rehfeld J.F. Peptide hormones and their prohormones as biomarkers. Biomark Med 2009, 3:335-338.
-
(2009)
Biomark Med
, vol.3
, pp. 335-338
-
-
Goetze, J.P.1
Rehfeld, J.F.2
-
105
-
-
77951900236
-
Simultaneous assessment of unprocessed ProBNP 1-108 in addition to processed BNP32 improves risk stratification in ambulatory patients with systolic heart failure
-
Dries D.J., Ky B., Wu A., Rame J.E., Putt M., Cappola T. Simultaneous assessment of unprocessed ProBNP 1-108 in addition to processed BNP32 improves risk stratification in ambulatory patients with systolic heart failure. Circ Heart Fail 2010, 3:220-227.
-
(2010)
Circ Heart Fail
, vol.3
, pp. 220-227
-
-
Dries, D.J.1
Ky, B.2
Wu, A.3
Rame, J.E.4
Putt, M.5
Cappola, T.6
-
106
-
-
0041467795
-
The paradox of increased natriuretic hormones in congestive heart failure patients: does the endocrine heart also fail in heart failure?
-
Goetze J.P., Kastrup J., Rehfeld J.F. The paradox of increased natriuretic hormones in congestive heart failure patients: does the endocrine heart also fail in heart failure?. Eur Heart J 2003, 24:1471-1472.
-
(2003)
Eur Heart J
, vol.24
, pp. 1471-1472
-
-
Goetze, J.P.1
Kastrup, J.2
Rehfeld, J.F.3
-
107
-
-
0036092948
-
Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing
-
Goetze J.P., Kastrup J., Pedersen F., Rehfeld J.F. Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem 2002, 48:1035-1042.
-
(2002)
Clin Chem
, vol.48
, pp. 1035-1042
-
-
Goetze, J.P.1
Kastrup, J.2
Pedersen, F.3
Rehfeld, J.F.4
-
108
-
-
79952661776
-
Pro-B-type natriuretic peptide 1-108 circulates in the general community: plasma determinants and detection of left ventricular systolic dysfunction
-
Macheret F., Boerrigter G., McKie P., et al. Pro-B-type natriuretic peptide 1-108 circulates in the general community: plasma determinants and detection of left ventricular systolic dysfunction. J Am Coll Cardiol 2011, 57:1386-1395.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 1386-1395
-
-
Macheret, F.1
Boerrigter, G.2
McKie, P.3
-
109
-
-
0036136991
-
Molecular forms of human brain natriuretic peptide in plasma
-
Shimizu H., Masuta K., Aono K., et al. Molecular forms of human brain natriuretic peptide in plasma. Clin Chim Acta 2002, 316:129-135.
-
(2002)
Clin Chim Acta
, vol.316
, pp. 129-135
-
-
Shimizu, H.1
Masuta, K.2
Aono, K.3
-
110
-
-
12444278136
-
Characterization of molecular forms of probrain natriuretic peptide in human plasma
-
Shimizu H., Masuta K., Asada H., Sugita K., Sairenji T. Characterization of molecular forms of probrain natriuretic peptide in human plasma. Clin Chim Acta 2003, 334:233-239.
-
(2003)
Clin Chim Acta
, vol.334
, pp. 233-239
-
-
Shimizu, H.1
Masuta, K.2
Asada, H.3
Sugita, K.4
Sairenji, T.5
-
111
-
-
33745685440
-
The precursor to B-type natriuretic peptide is an O-linked glycoprotein
-
Schellenberger U., O'Rear J., Guzzetta A., Jue R.A., Protter A.A., Pollitt N.S. The precursor to B-type natriuretic peptide is an O-linked glycoprotein. Arch Biochem Biophys 2006, 451:160-166.
-
(2006)
Arch Biochem Biophys
, vol.451
, pp. 160-166
-
-
Schellenberger, U.1
O'Rear, J.2
Guzzetta, A.3
Jue, R.A.4
Protter, A.A.5
Pollitt, N.S.6
-
112
-
-
43449117210
-
Immunodetection of glycosylated NT-proBNP circulating in human blood
-
Seferian K.R., Tamm N.N., Semenov A.G., et al. Immunodetection of glycosylated NT-proBNP circulating in human blood. Clin Chem 2008, 54:866-873.
-
(2008)
Clin Chem
, vol.54
, pp. 866-873
-
-
Seferian, K.R.1
Tamm, N.N.2
Semenov, A.G.3
-
113
-
-
44949096268
-
A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric protein
-
Crimmins D.L., Kao J.L. A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric protein. Arch Biochem Biophys 2008, 475:36-41.
-
(2008)
Arch Biochem Biophys
, vol.475
, pp. 36-41
-
-
Crimmins, D.L.1
Kao, J.L.2
-
114
-
-
62149147584
-
Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site
-
Semenov A.G., Postnikov A.B., Tamm N.N., et al. Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site. Clin Chem 2009, 55:489-498.
-
(2009)
Clin Chem
, vol.55
, pp. 489-498
-
-
Semenov, A.G.1
Postnikov, A.B.2
Tamm, N.N.3
-
115
-
-
79960584348
-
Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure
-
Miller W.L., Phelps M.A., Wood C.M., et al. Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure. Circ Heart Fail 2011, 4:355-360.
-
(2011)
Circ Heart Fail
, vol.4
, pp. 355-360
-
-
Miller, W.L.1
Phelps, M.A.2
Wood, C.M.3
-
116
-
-
77954357982
-
Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases
-
Semenov A.G., Tamm N.N., Seferian K.R., et al. Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases. Clin Chem 2010, 56:1166-1176.
-
(2010)
Clin Chem
, vol.56
, pp. 1166-1176
-
-
Semenov, A.G.1
Tamm, N.N.2
Seferian, K.R.3
-
117
-
-
79953182303
-
Ectodomain shedding and autocleavage of the cardiac membrane protease corin
-
Jiang J., Wu S., Wang W., et al. Ectodomain shedding and autocleavage of the cardiac membrane protease corin. J Biol Chem 2011, 286:10066-10072.
-
(2011)
J Biol Chem
, vol.286
, pp. 10066-10072
-
-
Jiang, J.1
Wu, S.2
Wang, W.3
-
118
-
-
0346732305
-
Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin
-
Knappe S., Wu F., Masikat M.R., Wu Q. Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin. J Biol Chem 2003, 278:52363-52370.
-
(2003)
J Biol Chem
, vol.278
, pp. 52363-52370
-
-
Knappe, S.1
Wu, F.2
Masikat, M.R.3
Wu, Q.4
-
119
-
-
77951936330
-
Plasma soluble corin in patients with heart failure
-
Dong N., Chen S., Yang J., et al. Plasma soluble corin in patients with heart failure. Circ Heart Fail 2010, 3:207-211.
-
(2010)
Circ Heart Fail
, vol.3
, pp. 207-211
-
-
Dong, N.1
Chen, S.2
Yang, J.3
-
120
-
-
79957775964
-
Human pro-B-type natriuretic peptide is processed in the circulation in a rat model
-
Semenov A.G., Seferian K.R., Tamm N.N., et al. Human pro-B-type natriuretic peptide is processed in the circulation in a rat model. Clin Chem 2011, 57:883-890.
-
(2011)
Clin Chem
, vol.57
, pp. 883-890
-
-
Semenov, A.G.1
Seferian, K.R.2
Tamm, N.N.3
-
121
-
-
79952691783
-
Natriuretic peptide assays revisited: do we need pro-B-type natriuretic peptide?
-
Emdin M., Passino C., Clerico A. Natriuretic peptide assays revisited: do we need pro-B-type natriuretic peptide?. J Am Coll Cardiol 2011, 57:1396-1398.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 1396-1398
-
-
Emdin, M.1
Passino, C.2
Clerico, A.3
-
122
-
-
84884222218
-
Recent advances on natriuretic peptide system: new promising therapeutic targets for the treatment of heart failure
-
Del Ry S., Cabiati M., Clerico A. Recent advances on natriuretic peptide system: new promising therapeutic targets for the treatment of heart failure. Pharmacol Res 2013, 76:190-198.
-
(2013)
Pharmacol Res
, vol.76
, pp. 190-198
-
-
Del Ry, S.1
Cabiati, M.2
Clerico, A.3
-
123
-
-
12944268361
-
Analytical performance and diagnostic accuracy of immunometric assays for the measurement of plasma BNP and NT-proBNP concentrations
-
Clerico A., Prontera C., Emdin M., et al. Analytical performance and diagnostic accuracy of immunometric assays for the measurement of plasma BNP and NT-proBNP concentrations. Clin Chem 2005, 51:445-447.
-
(2005)
Clin Chem
, vol.51
, pp. 445-447
-
-
Clerico, A.1
Prontera, C.2
Emdin, M.3
-
124
-
-
84880984012
-
Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials
-
Franzini M., Masotti S., Prontera C., et al. Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials. Clin Chim Acta 2013, 424:287-291.
-
(2013)
Clin Chim Acta
, vol.424
, pp. 287-291
-
-
Franzini, M.1
Masotti, S.2
Prontera, C.3
-
125
-
-
63849103296
-
Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure
-
Niederkofler E.E., Kiernan U.A., O'Rear J., et al. Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure. Circ Heart Fail 2008, 1:258-264.
-
(2008)
Circ Heart Fail
, vol.1
, pp. 258-264
-
-
Niederkofler, E.E.1
Kiernan, U.A.2
O'Rear, J.3
-
126
-
-
28444443740
-
Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure
-
Hawkridge A.M., Heublein D.M., Bergen H.R., Cataliotti A., Burnett J.C., Muddiman D.C. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci U S A 2005, 102:17442-17447.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 17442-17447
-
-
Hawkridge, A.M.1
Heublein, D.M.2
Bergen, H.R.3
Cataliotti, A.4
Burnett, J.C.5
Muddiman, D.C.6
-
127
-
-
84858615682
-
Comparison of novel pro-BNP1-108 and standard BNP assays in heart failure patients
-
Miller W.L., Grill D.E., Jaffe A.S. Comparison of novel pro-BNP1-108 and standard BNP assays in heart failure patients. Clin Chim Acta 2012, 413:920-926.
-
(2012)
Clin Chim Acta
, vol.413
, pp. 920-926
-
-
Miller, W.L.1
Grill, D.E.2
Jaffe, A.S.3
-
128
-
-
23844494143
-
Consensus document. Recommendations for the clinical use of cardiac natriuretic peptides
-
Emdin E., Clerico A., Clemenza F., et al. Consensus document. Recommendations for the clinical use of cardiac natriuretic peptides. J Cardiovasc Med (Ital Heart J) 2005, 6:430-446.
-
(2005)
J Cardiovasc Med (Ital Heart J)
, vol.6
, pp. 430-446
-
-
Emdin, E.1
Clerico, A.2
Clemenza, F.3
|